https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/accounts-payable https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/accounts-receivable https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/accrual-for-taxes-other-than-income-taxes-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/accrued-income-taxes-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/accumulated-depreciation https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/activist-13d-13g-form-sc-13d https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/activist-13d-13g-form-sc-13g https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/additional-paid-in-capital https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/adjustment-for-amortization https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/advances-on-inventory-purchases https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/allowance-for-doubtful-accounts-receivable https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/allowance-for-doubtful-accounts-receivable-charge-offs https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/allowance-for-doubtful-accounts-receivable-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/amended-reports-10-k https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/amended-reports-10-q https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/amortization https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/aoci https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/buildings-and-improvements-gross https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/capital-expenditures https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/capital-expenditures-incurred-but-not-yet-paid https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/capital-lease-obligations https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/capitalized-computer-software-additions https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/cash-and-equivalents https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/cash-flow-breakdown https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/class-of-warrant-or-right-exercise-price-of-warrants-or-rights https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/class-of-warrant-or-right-outstanding https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/common-stock-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/comprehensive-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/construction-in-progress-gross https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/cost-of-revenue https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/cover-page-shares-outstanding https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/current-assets https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/current-income-tax-expense-benefit https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/current-liabilities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/customer-deposits-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/debt-interest-rate-effective-percentage https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/debt-interest-rate-stated-percentage https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/debt-issued https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/debt-repaid https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/deferred-income-tax-expense-benefit https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/deferred-tax-assets-gross https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/defined-contribution-plan-employer-discretionary-contribution-amount https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/depreciation https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/due-to-employees-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/due-to-officers-or-stockholders-current-and-noncurrent https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/due-to-related-parties-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/entity-wide-revenue-major-customer-percentage https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/equity-fair-value-adjustment https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/equity-method-investment-summarized-financial-information-gross-profit-loss https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/equity-method-investment-summarized-financial-information-net-income-loss https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/equity-method-investment-summarized-financial-information-revenue https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/equity-method-investment-unrealized-intercompany-profit-loss-not-eliminated-amount https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/equity-method-investments https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/exchange-rate-effect-on-cash https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/financing-cash-flow https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/finite-lived-intangible-assets-amortization-expense-next-rolling-twelve-months https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/finite-lived-intangible-assets-amortization-expense-rolling-after-year-five https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-five https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-four https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-three https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/finite-lived-intangible-assets-amortization-expense-rolling-year-two https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/foreign-earnings https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/gain-loss-on-disposition-of-property https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/gross-profit https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/guarantee-obligations-current-carrying-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/guarantee-obligations-maximum-exposure https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/income-loss-from-equity-method-investments https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/income-tax https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/income-taxes-paid https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-accounts-receivable https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-accrued-taxes-payable https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-due-to-related-parties https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-inventories https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-notes-receivables https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-other-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-other-operating-liabilities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/insider-transactions-stock-options https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/intangible-assets-net-excluding-goodwill https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/interest-and-debt-expense https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/interest-costs-capitalized https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/interest-costs-incurred-capitalized https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/interest-expense-on-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/interest-expense-related-party https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/interest-paid https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/inventory https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/inventory-finished-goods https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/inventory-raw-materials https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/inventory-work-in-process https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/investing-cash-flow https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/investment-income-interest https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/investment-income-net https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/late-filing-notices-nt-10-k https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/late-filing-notices-nt-10-q https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/machinery-and-equipment-gross https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/net-change-in-cash https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/net-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/noncash-or-part-noncash-acquisition-fixed-assets-acquired https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/notes-and-loans-receivable-net-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/notes-payable-to-bank-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax-change https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/operating-cash-flow https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/operating-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/operating-loss-carryforwards https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/other-accrued-liabilities-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/other-current-liabilities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/other-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/other-nonoperating-expense https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/other-nonoperating-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/other-receivables-net-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/paid-in-capital-share-based-compensation-stock-options-requisite-service-period-recognition https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/payments-to-acquire-equity-method-investments https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/payments-to-acquire-intangible-assets https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/payments-to-acquire-other-productive-assets https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/payments-to-fund-longterm-loans-to-related-parties https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/preferred-shares-facts https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/preferred-stock-shares-authorized https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/preferred-stock-shares-issued https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/preferred-stock-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/prepaid-expense-and-other-assets-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/prepaid-expense-noncurrent https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/pretax-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-advances-for-construction https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-bank-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-income-tax-refunds https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-repayments-of-restricted-cash-financing-activities https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/proceeds-from-repayments-of-short-term-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/property-plant-and-equipment-gross https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/property-plant-equipment https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/provision-for-doubtful-accounts https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/public-float https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/repayments-of-bank-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/repayments-of-long-term-capital-lease-obligations https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/repayments-of-other-short-term-debt https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/restricted-cash-and-cash-equivalents https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/restricted-cash-and-cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/retained-earnings-appropriated https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/retained-earnings-unappropriated https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/revenue https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sale-leaseback-transaction-gross-proceeds https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-comment-letters-corresp https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-comment-letters-upload https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-10-k https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-10-q https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-10ksb https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-10qsb https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-10sb12g https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-15-12g https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-8-k https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-def-14a https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-def-14c https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-defa14a https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-pre-14a https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-pre-14c https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-regdex https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sec-filings-sc-14f1 https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/secondary-offerings-form-424b3 https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/secondary-offerings-form-effect https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/secondary-offerings-form-pos-am https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/secondary-offerings-form-rw https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/secondary-offerings-form-s-1 https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/secondary-offerings-form-s-8 https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/sga-expense https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/shareholders-equity https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/shares-authorized https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/shares-issued https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/shipping-handling-and-transportation-costs https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/short-term-borrowings https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-award-options-exercises-in-period-average-exercise-price https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-award-options-forfeitures-in-period-average-exercise-price https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-award-options-grants-in-period-average-exercise-price https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-based-compensation https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-compensation-unrecognized-cost https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-exercises-in-period-total-intrinsic-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-forfeitures-in-period https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-grants-in-period https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-grants-in-period-grant-date-intrinsic-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-outstanding-average-exercise-price https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-outstanding-intrinsic-value https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-outstanding-number https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-vested-and-expected-to-vest-outstanding-average-exercise-price https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/stock-options-vested-and-expected-to-vest-outstanding-number https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/tax-credit-carryforward-amount https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/tax-reconciliation-tax-exempt-income https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/taxes-payable-current https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/total-assets https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/total-liabilities-and-equity https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/utilities-operating-expense-maintenance-operations-and-other-costs-and-expenses https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/shengtai-pharmaceutical-inc/weighted-average-number-of-share-outstanding-basic-and-diluted